Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Boonkaya S, Pattarawongpaiboon C, Thaimai P, Ananchuensook P, et al. Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study. PLoS One 2025;20:e0337351.
PMID: 41411278


Privacy Policy